Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
Go back to Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release(NASDAQ: SAVA) | Delayed: 21.63 +0.89 (4.29%) | |||||
---|---|---|---|---|---|---|
Previous Close | $20.74 | 52 Week High | $ | |||
Open | $20.58 | 52 Week Low | $ | |||
Day High | $21.88 | P/E | N/A | |||
Day Low | $20.43 | EPS | $ | |||
Volume | 530,350 |